Skip to main content
. 2021 May 10;27(8):973–986. doi: 10.1111/cns.13654

FIGURE 5.

FIGURE 5

Evaluation of immunotherapy in glioma with risk score in REMBRANDT cohort. A, The relationship between risk score and immune infiltration score. B, Shows the relationship of the risk score and the immune score. C, Correlation between the risk score and cancer immunity cycles. D, Correlation between the risk score and PD‐L1 expression. E, Shows spearman correlation analysis reflecting the relationship of risk score and immune checkpoint blockade‐related pathways